New Aspects of Vitamin K Prophylaxis

ABSTRACT

Vitamin K-deficiency bleeding (VKDB) is rare, unpredictable, and life-threatening. Warning signs such as minimal bleeds, evidence of cholestasis, and failure to thrive often are present but overlooked. Therefore VK prophylaxis is necessary, at least for breastfed infants. Most effective is the intramuscular application, which unfortunately has real disadvantages (trauma, poor acceptance by parents) and potential risks due to very high VK levels, since VK affects not only coagulation but all processes associated with carboxylation.

Three oral doses of VK protect many babies (2-mg doses giving better protection than 1 mg) but the prevention of VKDB is not assured even with the mixed-micelle preparation. Use of small VK doses either daily or weekly seems to give effective prophylaxis without the adverse effects of intramuscular VK application.

The risks of VKDB are minimized if prophylaxis recommendations are followed and if warning signs are recognized and promptly acted upon. The next goal is the search for methods of identifying early the few infants destined to bleed so that targeted prophylaxis can replace the current “prophylaxis for all.”

KEYWORDS

Vitamin K deficiency bleeding - hemorrhagic disease of the newborn - Vitamin K prophylaxis

REFERENCES

• 1 Sutor A H, von Kries R, Cornelissen E AM, McNinch A W, Andrew M. Vitamin K deficiency bleeding (VKDB) in infancy. On behalf of the ISTH Pediatric/Perinatal Subcommittee.  Thromb Haemost . 1999;  81 456-461
• 2 Suzuki S, Iwata G, Sutor A H. Vitamin K deficiency during the perinatal and infantile period.  Semin Thromb Hemost . 2001;  27 93-98
• 3 Golding J, Greenwood R. Intramuscular vitamin K and childhood cancer: two British studies. In: Sutor AH, Hathaway WE, eds. Vitamin K in Infancy Stuttgart, Germany: Schattauer 1995: 283-289
• 4 Tripp J H, McNinch A W. The vitamin K debacle: cut the Gordian knot but first do no harm.  Arch Dis Child . 1998;  79 295-299
• 5 Shearer M. Vitamin K metabolism and nutriture.  Blood Rev . 1992;  6 92-104
• 6 Sutor A H. Vitamin K deficiency bleeding.  Semin Thromb Hemost . 1995;  21 317-329
• 7 Cornelissen E AM, Kolle L AA, van Lith T P J G, Motohara K, Monnens L AH. Evaluation of a daily dose of 25 μg vitamin K₁ to prevent vitamin K deficiency in breastfed infants.  J Pediatr Gastroenterol Nutr . 1993;  16 301-305
• 8 McNinch A W, Upton C, Samuels M. et al . Plasma concentrations after oral or intramuscular vitamin K1 in neonates.  Arch Dis Child . 1985;  60 814-818
• 9 von Kries R, Hachmeister A, Göbel U. Repeated oral vitamin K prophylaxis in Germany: acceptance and efficacy.  Br Med J . 1995;  310 1097-1098
• 10 von Kries R, Hachmeister A, Göbel U. Can 3 oral 2-mg doses of vitamin K effectively prevent late vitamin K-deficiency bleeding?.  Eur J Pediatr . 1999;  158(Suppl 3) S183-186
• 11 Hansen K N, Minousis M, Ebbesen F. Continuous oral vitamin K prophylaxis in Denmark.  Acta Paediatr . 2003;  92 802-805
• 12 Cornelissen E AM, von Kries R, Loughnan P, Schubiger G. Prevention of vitamin K deficiency-bleeding: efficacy of different multiple oral dose schedules of vitamin K.  Eur J Pediatr . 1997;  156 126-130
• 13 Loughnan P, McDougall P M. The duration of vitamin K₁ efficacy: is intramuscular vitamin K1 acting as a depot preparation?. In: Sutor AH, Hathaway WE, eds. Vitamin K in Infancy Stuttgart, Germany: Schattauer 1995: 225-234
• 14 Cornelissen E AM. Vitamin-K-Prophylaxe bei Neugeborenen.  Pädiat Prax . 2001;  59 206
• 15 von Kries R, Göbel U. Vitamin K prophylaxis and late hemorrhagic disease of the newborn.  Acta Paediatr Scand . 1992;  81 655-657
• 16 von Kries R. Vitamin-K-Mangelblutungen.  Monatschr Kinderheilk . 2001;  11 1272-1273
• 17 Crowther C A, Henderson-Smart D J. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage.  Cochrane Database Syst Rev . 2001;  1 CD000229
• 18 Roman E, Fear N T, Ansell P. et al . Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies.  Br J Cancer . 2002;  7 63-69
• 19 Seidelin J, Pedersen B L, Mogensen T S. Risk management by reporting critical incidents. Vitamin K and ephedrine mix-up at a birthing unit.  Ugeskr Laeger . 2001;  163 5365-5367
• 20 Kumar D, Greer F R, Super D M, Suttie J W, Moore J J. Vitamin K status of premature infants: implications for current recommendations.  Pediatrics . 2001;  108 1117-1122
• 21 Wilson D C, Rashid M, Durie P R. et al . Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin combination.  J Pediatr . 2001;  138 851-855
• 22 Zipursky A. Vitamin K at birth [editorial].  Br Med J . 1996;  313 179-180